DRKS00032532
Recruiting
Not Applicable
Prospective, multi-centre, non-interventional study on the use, tolerability and safety of the One Strength dose escalation scheme with NOVo Helisen® hoUSe dust mites in everyday practice - NOVUS
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- J30.3
- Sponsor
- Allergopharma GmbH & Co. KG
- Enrollment
- 1000
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Written informed consent from the patient. In the case of patients under the age of 18, the consent of both parents/legal guardians is also required.
- •2\. Patients treatment with the One\-Strength dose escalation scheme of NH (D.p./D.f.) must be approved, in accordance with the specifications of the SmPC. This includes adolescents (\=12 and \<18 years) and adults with allergic (IgE\-mediated) diseases such as allergic rhinitis, allergic conjunctivitis, allergic bronchial asthma (see section 4 of the current SmPC).
- •3\. The therapy decision must precede the decision to participate in the study and must be independent.
Exclusion Criteria
- •1\. Any contraindication according to section 4\.3 of the current SmPC for NH (D.p./D.f.) for the One\-Strength dose escalation scheme.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A non-interventional, prospective, multicenter study to describe patient preference and real-world outcomes of Diroximel Fumarate for the treatment of relapsing remitting multiple sclerosis in daily clinical practiceG35.1DRKS00029567Biogen GmbH118
Active, not recruiting
Phase 4
A multi-hospital approach that depicts the routine practice of doctors treating patients with type 2 diabetes with Novomix 30, which will evaluate willingness and ability to pay in a real world population.CTRI/2017/10/010218ovo Nordisk India Private Ltd
Completed
Not Applicable
A multicenter, prospective, non-interventional observational study to determine LDL-C goal attainment rate in elderly patients with dyslipidemia receiving Mevalotin® Tab.KCT0003190Daiichi-Sankyo Korea3,000
Not yet recruiting
Phase 4
A Non-interventional, observational Post Marketing Surveillance (PMS) Study of AdaliRelTM (Adalimumab) in Patients With Active Rheumatoid arthritis.CTRI/2020/04/024644Reliance Life Sciences Pv Ltd
Recruiting
Not Applicable
Multi-center, Prospective, Non-interventional, Observational Cohort Study to Investigate Effectiveness and Safety of Rivaroxaban on Prevention of Stroke and Systemic Embolism in Patients with Non-valvular Atrial Fibrillation in Japanese Clinical Practiceon-valvular atrial fibrillation (In the present study, non-valvular atrial fibrillation refers to atrial fibrillation without a history of prosthetic valve replacement or mitral valve stenosis.)JPRN-UMIN000009376Tohoku University School of Medicine7,000